MHRA Drug Safety Update January 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 6 January 2022) has been published and includes articles on:

• Brolucizumab (Beovu▼): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals
• Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error
• COVID-19 vaccines and medicines: updates for January 2021
• Letters and medicine recalls sent to healthcare professionals in December 2021

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website